{"id":1101,"date":"2022-10-25T19:14:48","date_gmt":"2022-10-26T00:14:48","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=1101"},"modified":"2022-12-13T11:21:59","modified_gmt":"2022-12-13T17:21:59","slug":"merck-to-donate-ebola-vaccine-candidate-for-research-program-in-uganda","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/10\/25\/merck-to-donate-ebola-vaccine-candidate-for-research-program-in-uganda\/","title":{"rendered":"Merck to donate Ebola vaccine candidate for research program in Uganda"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p>(<a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/merck-donate-ebola-vaccine-candidate-research-program-uganda-2022-10-25\/\">Reuters<\/a>) Merck said on Tuesday it was planning to produce and donate investigational Sudan ebolavirus vaccine to a global non-profit organization&#8217;s research program in Uganda, which is facing an outbreak of the disease. The investigational vaccine that will be donated to IAVI is similar to Merck&#8217;s Ervebo vaccine, which is approved against the Zaire ebolavirus strain.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>(Reuters) Merck said on Tuesday it was planning to produce and donate investigational Sudan ebolavirus vaccine to a global non-profit organization&#8217;s research program in Uganda, which is facing an outbreak of the disease. The investigational vaccine that will be donated to IAVI is similar to Merck&#8217;s Ervebo vaccine, which is approved against the Zaire ebolavirus [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[9,8],"tags":[],"class_list":["post-1101","post","type-post","status-publish","format-standard","hentry","category-ebola","category-vaccine-headlines"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=1101"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1101\/revisions"}],"predecessor-version":[{"id":1102,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1101\/revisions\/1102"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=1101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=1101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=1101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}